Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2015 Nov 4;11(1):9–25. doi: 10.1007/s11481-015-9637-6

Table 4.

Activity testing results

Activity Test Non Transgenic mean +/− SEM rTg4510 + IgG1 mean +/− SEM rTg4510 + MC-1 Mean +/− SEM rTg4510 + Tau 5 Mean +/− SEM
Open Field Distance Traveled 50.6 +/− 5.9 126 +/− 28 149 +/− 26 143 +/− 26
Rotarod – Total time 40.5 +/− 5.1 57.3 +/− 6.7 44.4 +/− 6.7 48.2 +/− 6.0
Y-Maze – Number of Entries 38.9 +/− 3.6 51.8 +/− 10.1 44.4 +/− 8.9 46.4 +/− 4.8
Y-Maze - Alternations 55.2 +/− 3.7 58.3 +/− 6.4 64.0 +/− 5.8 61.4 +/− 4.2

Our laboratory has observed that rTg4510 mice typically display much greater activity levels than NonTg mice, as mentioned above. Such activity is demonstrated here, by comparing distance traveled in the Open Field test, the time on the Rotarod and the number of entries in the Y-Maze. Slight increases are also shown in the number of alternations in the Y-Maze. Treatment of the rTg4510 mice with either MC-1 or Tau 5 did not significantly impact performance compared to IgG1 treatment.